Reconciling heterogeneous dengue virus infection risk estimates from different study designs

A Angkana T. Huang (Department of Genetics) D Darunee Buddhari (Department of Virology) S Surachai Kaewhiran (Department of Disease Control, Ministry of Public Health) S Sopon Iamsirithaworn (Department of Disease Control, Ministry of Public Health) D Direk Khampaen (Department of Disease Control, Ministry of Public Health) A Aaron Farmer (Department of Virology) S Stefan Fernandez (Department of Virology) S Stephen J. Thomas (Microbiology and Immunology, State University of New York Upstate Medical University) I Isabel Rodriguez-Barraquer (School of Medicine, University of California) T Taweewun Hunsawong (Department of Virology) A Anon Srikiatkhachorn (Department of Virology) G Gabriel Ribeiro dos Santos (Department of Genetics) M Megan O’Driscoll (Department of Genetics) M Marco Hamins-Puertolas (School of Medicine, University of California) T Timothy Endy (Coalition for Epidemic Preparedness Innovations) A Alan L. Rothman (Laboratory of Viral Immunity and Pathogenesis, University of Rhode Island) D Derek A. T. Cummings (Department of Biology) K Kathryn Anderson (Microbiology and Immunology, State University of New York Upstate Medical University) H Henrik Salje

Abstract

Uncovering rates at which susceptible individuals become infected with a pathogen, i.e., the force of infection (FOI), is essential for assessing transmission risk and reconstructing distribution of immunity in a population. For dengue, reconstructing exposure and susceptibility statuses from the measured FOI is of particular significance as prior exposure is a strong risk factor for severe disease. FOI can be measured via many study designs. Longitudinal serology is considered gold standard measurements, as they directly track the transition of seronegative individuals to seropositive due to incident infections (seroincidence). Cross-sectional serology can provide estimates of FOI by contrasting seroprevalence across ages. Age of reported cases can also be used to infer FOI. Agreement of these measurements, however, has not been assessed. Using 26 y of data from cohort studies and hospital-attended cases from Kamphaeng Phet province, Thailand, we found FOI estimates from the three sources to be highly inconsistent. Annual FOI estimates from seroincidence were 1.75 to 4.05 times higher than case-derived FOI. Seroprevalence-derived was moderately correlated with case-derived FOI (correlation coefficient = 0.47) with slightly lower estimates. Through extensive simulations and theoretical analysis, we show that incongruences between methods can result from failing to account for dengue antibody kinetics, assay noise, and heterogeneity in FOI across ages. Extending standard inference models to include these processes reconciled the FOI and susceptibility estimates. Our results highlight the importance of comparing inferences across multiple data types to uncover additional insights not attainable through a single data type/analysis.

Article Details

Volume / Issue Vol. 122, Issue 1
Published January 07, 2025
ISSN 0027-8424
Publisher National Academy of Sciences

Authors (19)

A

Angkana T. Huang

Department of Genetics

D

Darunee Buddhari

Department of Virology

S

Surachai Kaewhiran

Department of Disease Control, Ministry of Public Health

S

Sopon Iamsirithaworn

Department of Disease Control, Ministry of Public Health

D

Direk Khampaen

Department of Disease Control, Ministry of Public Health

A

Aaron Farmer

Department of Virology

S

Stefan Fernandez

Department of Virology

S

Stephen J. Thomas

Microbiology and Immunology, State University of New York Upstate Medical University

I

Isabel Rodriguez-Barraquer

School of Medicine, University of California

T

Taweewun Hunsawong

Department of Virology

A

Anon Srikiatkhachorn

Department of Virology

G

Gabriel Ribeiro dos Santos

Department of Genetics

M

Megan O’Driscoll

Department of Genetics

M

Marco Hamins-Puertolas

School of Medicine, University of California

T

Timothy Endy

Coalition for Epidemic Preparedness Innovations

A

Alan L. Rothman

Laboratory of Viral Immunity and Pathogenesis, University of Rhode Island

D

Derek A. T. Cummings

Department of Biology

K

Kathryn Anderson

Microbiology and Immunology, State University of New York Upstate Medical University

H

Henrik Salje